Safe Supply Streaming Co Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe Supply" or "the Company") is a publicly-traded company that specializes in the acquisition, investment,...
OS Therapies is advancing therapies focused on HER-2 positive osteosarcoma, addressing a critical unmet need.
The company draws inspiration from "Osteo-Angels," individuals whose battles against...
ROCKVILLE, Md. & NEW YORK, August 02, 2024--(BUSINESS WIRE)--OS Therapies Incorporated ("OS Therapies" or the "Company") (NYSE-A: OSTX), a Cancer Immunotherapy and Antibody Drug Conjugate...
OS Therapies focuses on developing advanced treatments for osteosarcoma, addressing a significant unmet medical need.
With an estimated $1.72 billion market for osteosarcoma and a...
NurExone Biologics is developing exosome-based therapies for non-invasive treatment of central nervous system injuries, with their lead product, ExoPTEN, showing significant promise in preclinical...